through the Integration of Biosensing and AI
Ultra-Precision Sensing Technology
Model BA200
Designed for non-invasive point-of-care assessment of airway inflammation, this device combines high-sensitivity biosensor technology (0.1 ppb) with full ATS/ERS compliance. It delivers multi-parameter results—FeNO, CaNO, FnNO—in under one minute, while a patented dual-channel design ensures complete protection against cross-contamination.
More
Driven by a passion for innovation and a commitment to excellence, desire to maintain high levels of innovation, knowledge, technical expertise, service.
Committed to providing solutions for respiratory diseases, cardiovascular diseases and metabolic diseases
Become a global provider in comprehensive chronic disease solution for both professional segment and homecare.
What Is Impulse Oscillometry? Imagine a lung function test that requires nothing more than sitting still and breathing normally. That is precisely what Impulse Oscillometry (IOS) offers—a quiet, non-invasive technology that uses sou...
Fractional exhaled nitric oxide (FeNO) has become an indispensable tool in respiratory medicine. As a non-invasive biomarker of Type-2 airway inflammation, FeNO testing is now widely used in asthma diagnosis, monitoring, and treatment gui...
Introduction Fractional exhaled nitric oxide (FeNO) has become a cornerstone in the management of asthma and other airway diseases. As a non‑invasive biomarker of type‑2 inflammation, it helps clinicians diagnose eosinophilic asthma, pr...
Please complete the form to contact our team